Home
About
Help
Alert
Account
Login
Create
Back to Search Results
Search
Advanced
Search
Find article
Advanced search
Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma
Kamdar, M.
;
Li, H.
;
Chen, R. W.
;
Rimsza, L. M.
;
Leblanc, M. L.
;
Fenske, T. S.
;
Shea, T. C.
;
Barr, P. M.
;
Phillips, T. J.
;
Leonard, J. P.
;
Kahl, B. S.
;
Friedberg, J. W.
;
Smith, S. M.
Blood advances. 2019;3(20):3132-3135
Full text from:
PubMed Central
Subscription
Elsevier Science
Silverchair Information Systems
Other resources
View in PubMed
Genetic Alliance
Study details
Study Design :
Randomised Controlled Trial
Transplant Type :
Autologous
Treatment :
Conditioning Regimens
Condition :
Haematological, Malignant
;
Haematological, Malignant/Non-Hodgkin Lymphoma
Language :
eng
Credits :
Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine